MedCity News January 6, 2021
Elise Reuter

AmerisourceBergen plans to buy most of Walgreens’ Alliance Healthcare business for $6.5 billion. The deal will let Walgreens focus more on its retail pharmacy and healthcare businesses.

Walgreens Boots Alliance plans to sell its pharmacy wholesale business to AmerisourceBergen for $6.5 billion, the companies announced on Wednesday.

The transaction will include $6.27 billion in cash and 2 million shares of AmerisourceBergen’s stock.

Walgreens will sell most of its Alliance Healthcare business, one of the largest pharmaceutical wholesalers in Europe. AmerisourceBergen CEO Steven Collis said the deal would expand the company’s reach and add to the breadth and depth of its global manufacturing services. In fiscal year 2020, Walgreens’ wholesale business brought in roughly $19 billion in revenue.

In turn, Walgreens...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension
AstraZeneca plans independent drug supply chains for US and China, CEO says
Digital Platforms Streamline Medication Access and Delivery
Pharma Pulse 3/27/24: Patients Hate ‘Forever’ Drugs—Is Wegovy Different? Low Melatonin Can Increase Risk of Neurological Disorders & more
Brainomix AI shows its worth in AZ pulmonary fibrosis trial

Share This Article